Quantitative theories of T-cell responsiveness

Immunological Reviews

Volumn 216, Issue 1, 2007, Pages 81-92

  Van Den Berg, Hugo A ^a   Rand, David A ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Avidity spectrum; Mathematical modeling; T cell receptor; T cell response; Tolerance

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTATION; CELLULAR IMMUNITY; CROSS REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; KINETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; MATHEMATICAL PARAMETERS; PRIORITY JOURNAL; PROTEIN MODIFICATION; QUANTITATIVE ANALYSIS; RECEPTOR AFFINITY; REVIEW; STATISTICS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; THEORETICAL MODEL;

ANIMALS; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 33947268563     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2006.00491.x     Document Type: Review

References (91)

1. Goldrath AW, Bevan MJ. Selecting and maintaining a diverse T-cell repertoire. Nature 1999;402:255-262.
2. Perelson AS, Weisbuch G. Immunology for physicists. Rev Mod Phys 1997;69:1219-1267.
3. Arstila TP, Casrouge A, Baron B, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human α-β T cell receptor diversity. Science 1999;286:958-961.
4. Kesxmir CJ, Borghans AM, de Boer RJ. Diversity of human αβ T cell receptors. Science 2000;288:1135a.
5. Kappler JW, Roehm N, Marrack P. T cell tolerance by clonal elimination in the thymus. Cell 1987;49:273-280.
6. Kisielow P, Blüthmann H, Staerz UD, Steinmetz M, von Boehmer H. Tolerance in T-cell-receptor transgenic mice involves deletion of nonmature CD4+8+ thymocytes. Nature 1988;333:742-746.
7. Laufer TM, Fan L, Glimcher LH. Self-reactive T cells selected on thymic cortical epithelium are polyclonal and are pathogenic in vivo. J Immunol 1999;162:5078-5084.
8. Annacker O, Pimenta-Araujo R, Burlen-Defranoux O, Bandeira A. On the ontology and physiology of regulatory T cells. Immunol Rev 2001;182:5-17.
9. Roncarolo M-G, Levings MK. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol 2000;12:676-683.
10. Zheng Y, Manzotti CN, Liu M, Burke F, Mead KI, Sansom DM. CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells. J Immunol 2004;172:2778-2784.
11. Salomon B, Bluestone JA. Complexities of CD28/B7: CTLA-4 costimulatory pathways in autoimmunity and transplantation. Annu Rev Immunol 2001;19:225-252.
12. Thompson CB, Allison JP. The emerging role of CTLA-4 as an immune attenuator. Immunity 1997;7:445-450.
13. Davis MM, et al. Dynamics of cell surface molecules during T cell recognition. Annu Rev Biochem 2003;72:717-742.
14. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998;19:395-404.
15. Abderson AC, et al. Autoantigen-responsive T cell clones demonstrate unfocused TCR cross-reactivity toward multiple related ligands: implications for autoimmunity. Cell Immunol 2000;202:88-96.
16. Rudolph MG, Wilson IA. The specificity of TCR.pMCH interaction. Curr Opin Immunol 2002;14:52-65.
17. Garcia KC, et al. Structural basis of plasticity in T cell receptor recognition of a self peptide-MHC antigen. Science 1998;279:1166-1172.
18. Hemmer B, et al. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med 1997;185:1651-1659.
19. Hemmer B, Vergelli M, Pinilla C, Houghten R, Martin R. Probing degeneracy in T-cell recognition using peptide combinatorial libraries. Immunol Today 1998;19:163-168.
20. Ignatowicz L, Kappler J, Marrack P. The repertoire of T cells shaped by a single MHC/peptide ligand. Cell 1996;84:521-529.
21. Kersh GH, Allen PM. Structural basis for T cell recognition of altered peptide ligands: a single T cell receptor can productively recognize a large continuum of related ligands. J Exp Med 1996;184:1259-1268.
22. Mazza G, et al. Glimpses at the recognition of peptide/MHC complexes by T-cell antigen receptors. Immunol Rev 1998;163:187-196.
23. Ashton-Rickardt PG, Tonegawa S. A differential-avidity model for T-cell selection. Immunol Today 1994;15:362-366.
24. Alexander-Miller MA. Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection. Cell Immunol 2000;201:58-62.
25. Gross D-A, et al. High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy. J Clin Invest 2004;113:425-433.
26. Davis SJ, Ikemizu S, Evans EJ, Fugger L, Bakker TR, van der Merwe PA. The nature of molecular recognition by T cells. Nat Immunol 2003;4:1-8.
27. Stevanović S, Schild H. Quantitative aspects of T cell activation - peptide generation and editing by MHC class I molecule. Semin Immunol 1999;11:375-384.
28. Burroughs N, Kesxmir C, de Boer R. Discriminating self from nonself with short peptides from large proteomes. Immunogenetics 2004;56:311-320.
29. Werlen G, Palmer E. The TCR signalosome: a dynamic structure with expanding complexity. Curr Opin Immunol 2002;14:299-305.
30. Parham O. The Immue System. New York: Garland Publishing, 2000.
31. Rannessee H-G, Falk K, Rotzshke O. Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 1993;11:213-244.
32. De Boer RJ, Perelson AS. How diverse should the immune system be? Proc R Soc Lond B Biol Sci 1993;252:171-175.
33. Matzinger P. The danger model: a renewed sense of self. Science 2002;296:301-305.
34. Kalergis AM, et al. Efficient T cell activation requires an optimal dwell-time of interaction between the TCR and the pMHC complex. Nat Immunol 2001;2:229-234.
35. van den Berg HA, Burroughs N, Rand DA. Quantifying the strength of ligand antagonism in TCR triggering. Bull Math Biol 2002;64:781-808.
36. Lanzavecchia A, Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science 2000;290:92-97.
37. Pilyugin S, Mittler J, Antia R. Modeling T-cell proliferation: an investigation of the consequences of the Hayflick limit. J Theor Biol 1997;186:117-129.
38. Borghans JAM, Taams LS, Wauben MHM, de Boer R. Competition for antigenic sites during T cell proliferation: a mathematical interpretation of in vitro data. Proc Natl Acad Sci USA 1999;96:10782-10787.
39. Butz EA, Bevan MJ. Massive expansion of antigen-specific CD8pT cells during an acute virus infection. Immunity 1998;8:167-175.
40. Gavin MA, Bevan MJ. Increased peptide promiscuity provides a rationale for the lack of N regions in the neonatal T cell repertoire. Immunity 1995;3:793-800.
41. Alexander-Miller MA, Leggatt GR, Berzofsky JA. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc Natl Acad Sci USA 1996;93:4102-4107.
42. Dutton RW, Bradley LM, Swain SL. T cell memory. Annu Rev Immunol 1998;16:201-223.
43. Antia R, Pilyugin SS, Ahmed R. Models of immune memory: on the role of cross-reactive stimulation, competition, and homeostasis in maintaining immune memory. Proc Natl Acad Sci USA 1998;95:14926-14931.
44. Utzny C, Burroughs NJ. Stability of a diverse immunological memory is determined by T cell population dynamics. Bull Math Biol 2001;63:685-713.
45. Yates AJ, Callard RE. Cell death and the maintenance of immunological memory. Discr Cont Dynam Sys B 2001;1:43-60.
46. de Boer RJ, Hogeweg P. Immunological discrimination between self and non-self by precursor depletion and memory accumulation. J Theor Biol 1987;124:343-369.
47. Borghans JAM, Noest A, de Boer RJ. How specific should immunological memory be? J Immunol 1999;163:569-575.
48. Borghans J, de Boer RJ. Crossreactivity of the T-cell receptor. Immunol Today 1998;19:428-429.
49. Jordan MS, et al. Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide. Nat Immunol 2001;2:301-306.
50. Mason D. Some quantitative aspects of T cell repertoire se-lection: the requirement for regulatory T cells. Immunol Rev 2001;182:80-88.
51. León K, Faro J, Lage A, Carneiro J. Inverse correlation between the incidences of autoimmune disease and infection predicted by a model of T cell mediated tolerance. J Autoimmun 2004;22:31-42.
52. van den Berg HA, Rand DA. Foreignness as a matter of degree: the relative immunogenicity of peptide/MHC ligands. J Theor Biol 2004;231:535-548.
53. Slifka MK, et al. Preferential escape of subdominant CD8+T cells during negative selection results in an altered antiviral T cell hierarchy. J Immunol 2003;170:1231-1239.
54. Thomas R, Lipsky PE. Could endogenous selfpeptides presented by dendritic cells initiate rheumatoid arthritis? Immunol Today 1996;17:559-564.
55. Bona CA, Casares S, Brumeanu T-D. Towards development of T-cell vaccines. Immunol Today 1998;19:126-132.
56. van den Berg HA, Rand DA, Burroughs NJ. A reliable and safe T cell repertoire based on low-affinity T cell receptors. J Theor Biol 2001;209:465-486.
57. van den Berg HA, Rand DA. Antigen presentation on MHC molecules as a diversity filter that enhances immune efficacy. J Theor Biol 2003;224:249-267.
58. Noest AJ. Designing lymphocyte functional structure for optimal signal detection: voilà, T cells. J Theor Biol 2000;207:195-216.
59. van den Berg HA, Molina-París C. Thymic presentation of autoantigens and the efficiency of negative selection. J Theor Med 2003;5:1-22.
60. Segel LA, Lev Bar-Or R. On the role of feedback in promoting conflicting goals of the adaptive immune system. J Immunol 1999;163:1342-1349.
61. Callard RE, George AJT, Stark J. Cytokines, chaos, and complexity. Immunity 1999;11:507-513.
62. Yates AJ, Bergmann L, van Hemmen C, Stark J, Callard RE. Cytokine-modulated regulation of helper T cell populations. J Theor Biol 2000;205:539-560.
63. Utzny C, Burroughs NJ. Perturbation theory analysis of competition in a heterogeneous population. Physica D 2003;175:109-126.
64. Monks CRF, Freiberg BA, Kupfer H, Sciaky N, Kupfer A. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 1998;395:82-86.
65. Dustin ML, Shaw AA. Costimulation: building an immunological synapse. Science 1999;283:649-650.
66. Grakoui A, et al. The immunological synapse: a molecular machine controlling T cell activation. Science 1999;285:221-227.
67. Freiberg BA, et al. Staging and resetting T cell activation in SMACs. Nat Immunol 2002;3:911-917.
68. Veillette A, Latour S, Davidson D. Negative regulation of immunoreceptor signalling. Annu Rev Immunol 2002;20:669-707.
69. Wülfing C, Sumen C, Sjaastad MD, Wu LC, Dustin ML, Davis MM. Costimulation and endogenous MHC ligands contribute to T cell recognition. Nat Immunol 2002;3:42-47.
70. Chan C, George AJT, Stark J. Cooperative enhancement of specificity in a lattice of T cell receptors. Proc Natl Acad Sci USA 2001;98:5758-5763.
71. Hlavacek WS, Redondo A, Wofsy C, Goldstein B. Kinetic proofreading in receptor-mediated transduction of cellular signals: receptor aggregation, partially activated receptors, and cytosolic messengers. Bull Math Biol 2002;64:887-911.
72. Goldstein B, Faeder JR, Hlavacek W. Mathematical and computational models of immune-receptor signalling. Nat Rev Immunol 2004;4:445-456.
73. Kaufman M, Andris F, Leo O. A model for antigen-induced T cell unresponsiveness based on autophosphorylative protein tyrosine kinase activity. Int Immunol 1996;8:613-624.
74. Chan C, Stark J, George AJT. Feedback control of T-cell receptor activation. Proc R Soc Lond B Biol Sci 2004;271:931-939.
75. Wooldridge L, et al. Interaction between the CD8 coreceptor and MHC class I stabilizes TCR-antigen complexes at the cell surface. J Biol Chem 2005;280:27491-27501.
76. lck complexes. J Exp Med 2001;194:1485-1495.
77. König R. Interactions between MHC molecules and coreceptors of the TCR. Curr Opin Immunol 2002;14:75-83.
78. Garcia KC, Scott CA, Brunmark A, Carbone FR, Peterson PA, Teyton L. CD8 enhances formation of stable T-cell receptor/MHC class I molecule complexes. Nature 1996;384:577-581.
79. Luescher IF, et al. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes. Nature 1995;373:353-356.
80. McKeithan TW. Kinetic proofreading in T-cell receptor signal transduction. Proc Natl Acad Sci USA 1995;92:5042-5046.
81. Rabinowitz JD, Beeson C, Lyons DS, Davis MM, McConnell HM. Kinetic discrimination in T-cell activation. Proc Natl Acad Sci USA 1996;93:1401- 1405.
82. Schodin BA, Tsomides TJ, Kranz DM. Correlation between the number of T cell receptors required for T cell activation and TCR-ligand affinity. Immunity 1996;5:137-146.
83. Girgis L, Davis MM, Fazekas de St. Groth B. The avidity spectrum of T cell receptor interactions accounts for T cell anergy in a double transgenic model. J Exp Med 1999;189:265-277.
84. Chan C, George AFT, Stark J. T cell sensitivity and specificity - kinetic proofreading revisited. Discr Cont Dynam Sys B 2003;3:343-360.
85. Valitutti S, Lanzavecchia A. Serial triggering of TCRs: a basis for the sensitivity and specificity of antigen recognition. Immunol Today 1997;18:299-304.
86. Gonzales PA, et al. T-cell receptor binding kinetics required for T-cell activation depend on the density of the cognate ligand of the antigen-presenting cell. Proc Natl Acad Sci USA 2005;102:4824-4829.
87. Detours V, Mehr R, Perelson AS. A quantitative theory of affinity-driven T cell repertoire selection. J Theor Biol 1999;200:389-403.
88. van den Berg HA, Rand DA. Dynamics of T cell activation threshold tuning. J Theor Biol 2004;228:397-416.
89. Nowak MA, Tarczy-Hornoch K, Austyn JM. The optimal number of major histocompatibility molecules in an individual. Proc Natl Acad Sci USA 1992;89:10896-10899.
90. Borghans J, Noest A, de Boer RJ. Thymic selection does not limit the individual MHC diversity. Eur J Immunol 2003;33:3353-3358.
91. Müller V, Bonhoeffer S. Quantitative constraints on the scope of negative selection. Trends Immunol 2003;24:132-135.